TOP2A, DNA topoisomerase II alpha, 7153

N. diseases: 200; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE We finally obtained a list of only five genes (AGXT; ALDOB; CYP2E1; IGFBP3; TOP2A) that were differentially expressed in tumor and nontumor tissues across studies and were significantly correlated to HCC prognosis.Only AGXT had not been reported in HCC. 31771612 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE The PPI network indicated that DNA topoisomerase II alpha (TOP2 A) was the most prominent hub gene of miR-302b-5p in HCC. 31103408 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease CTD_human Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. 28284560 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma. 28599412 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE In conclusion, TOP2A overexpression in HCC was not secondary to gene amplification. 25695068 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE The aim of this study is to investigate the role and mechanism of mir-23a in enhancing the anti-tumor effect of topoisomerase 2A (TOP2A) poison etoposide in human hepatocellular carcinoma (HCC). 24103454 2013
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE We used quantitative RT-PCR in a cohort of normal liver tissue (n = 8), hepatitis C virus (HCV)-induced chronic liver disease (n = 9), and HCC (n = 7) to validate co-expressions of several well-connected genes, namely ASPM, CDKN3, NEK2, RACGAP1, and TOP2A. 22539975 2012
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE Distinct TOP2A transcriptions were confirmed in an independent series of HCC tumors relative to adjacent non-tumoral liver (p=0.0018). 19003983 2009